Log in

NYSE:LCILannett Stock Price, Forecast & News

$7.12
+0.05 (+0.71 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$7.06
Now: $7.12
$7.27
50-Day Range
$6.76
MA: $7.40
$8.35
52-Week Range
$5.46
Now: $7.12
$15.52
Volume325,079 shs
Average Volume485,114 shs
Market Capitalization$287.29 million
P/E RatioN/A
Dividend YieldN/A
Beta1.87
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, suspension, soft gel, and injectable dosages. It also provides its products for various medical indications comprising cholesterol, muscle spasm, pain management, irritable bowel, antipsychosis, gastrointestinal, cardiovascular, thyroid deficiency, central nervous system, urinary, migraine, bronchospasms, and gallstone. In addition, the company manufactures active pharmaceutical ingredients. It markets its products under the Lipitor, Lioresal, Bentyl, Prolixin, MiraLAX, Imdur, Levoxyl/Synthroid, Concerta, Toprol-XL, Prilosec, Ditropan, Protonix, Imitrex, Brethine, and Actigall brands to generic pharmaceutical and private label distributors, drug wholesalers, chain drug retailers, mail-order pharmacies, other pharmaceutical manufacturers, managed care and health maintenance organizations, hospital buying groups, and governmental entities. The company has supply and development agreements with Jerome Stevens Pharmaceuticals, Summit Bioscience LLC, HEC Pharm Group, Andor Pharmaceuticals LLC, Dexcel Pharma, and Aralez Pharmaceuticals. Lannett Company, Inc. was founded in 1942 and is based in Philadelphia, Pennsylvania.
Read More
Lannett logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.59 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP51601210
Phone215-333-9000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$655.41 million
Cash Flow$3.75 per share
Book Value$8.49 per share

Profitability

Net Income$-272,110,000.00

Miscellaneous

Employees1,020
Market Cap$287.29 million
Next Earnings Date8/25/2020 (Estimated)
OptionableOptionable

Receive LCI News and Ratings via Email

Sign-up to receive the latest news and ratings for LCI and its competitors with MarketBeat's FREE daily newsletter.

Lannett (NYSE:LCI) Frequently Asked Questions

How has Lannett's stock been impacted by COVID-19 (Coronavirus)?

Lannett's stock was trading at $7.74 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, LCI stock has decreased by 8.0% and is now trading at $7.12. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Lannett?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Lannett in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Lannett.

When is Lannett's next earnings date?

Lannett is scheduled to release its next quarterly earnings announcement on Tuesday, August 25th 2020. View our earnings forecast for Lannett.

How were Lannett's earnings last quarter?

Lannett Company, Inc. (NYSE:LCI) posted its earnings results on Wednesday, May, 6th. The company reported $0.27 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.28 by $0.01. The business had revenue of $144.37 million for the quarter, compared to analysts' expectations of $134.55 million. Lannett had a negative net margin of 5.77% and a positive return on equity of 14.54%. The firm's revenue for the quarter was down 16.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.68 earnings per share. View Lannett's earnings history.

What guidance has Lannett issued on next quarter's earnings?

Lannett updated its FY 2020 After-Hours earnings guidance on Wednesday, May, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $535-545 million, compared to the consensus revenue estimate of $541.95 million.

What price target have analysts set for LCI?

2 brokerages have issued 12-month price objectives for Lannett's stock. Their forecasts range from $14.00 to $14.00. On average, they anticipate Lannett's share price to reach $14.00 in the next year. This suggests a possible upside of 96.6% from the stock's current price. View analysts' price targets for Lannett.

Has Lannett been receiving favorable news coverage?

News articles about LCI stock have trended negative on Saturday, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Lannett earned a daily sentiment score of -2.4 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about Lannett.

Are investors shorting Lannett?

Lannett saw a decline in short interest during the month of June. As of June 15th, there was short interest totaling 9,680,000 shares, a decline of 7.0% from the May 31st total of 10,410,000 shares. Based on an average daily volume of 626,700 shares, the days-to-cover ratio is currently 15.4 days. Approximately 30.8% of the company's shares are short sold. View Lannett's Current Options Chain.

Who are some of Lannett's key competitors?

What other stocks do shareholders of Lannett own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lannett investors own include Celgene (CELG), Akorn (AKRX), Skechers USA (SKX), Integrated Device Technology (IDTI), Bank of America (BAC), Alibaba Group (BABA), Gilead Sciences (GILD), Micron Technology (MU), Rite Aid (RAD) and NVIDIA (NVDA).

Who are Lannett's key executives?

Lannett's management team includes the following people:
  • Mr. Timothy C. Crew, CEO & Director (Age 58)
  • Mr. Martin P. Galvan, VP of Fin. & CFO (Age 67)
  • Mr. Samuel H. Israel, Gen. Counsel & Chief Legal Officer (Age 57)
  • Mr. John M. Abt, VP & Chief Quality Operations Officer (Age 54)
  • Mr. John Kozlowski, Chief of Staff & Strategy Officer (Age 47)

What is Lannett's stock symbol?

Lannett trades on the New York Stock Exchange (NYSE) under the ticker symbol "LCI."

How do I buy shares of Lannett?

Shares of LCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Lannett's stock price today?

One share of LCI stock can currently be purchased for approximately $7.12.

How big of a company is Lannett?

Lannett has a market capitalization of $287.29 million and generates $655.41 million in revenue each year. The company earns $-272,110,000.00 in net income (profit) each year or $2.35 on an earnings per share basis. Lannett employs 1,020 workers across the globe.

What is Lannett's official website?

The official website for Lannett is www.lannett.com.

How can I contact Lannett?

Lannett's mailing address is 9000 STATE ROAD, PHILADELPHIA PA, 19136. The company can be reached via phone at 215-333-9000.

This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.